Support PenkeSPDR® S&P Pharmaceuticals ETF
Portfolio
Holdings
| Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACRS.NASDAQ | Aclaris Therapeutics Inc | USA | Healthcare | Diagnostics & Research | 2024-06-30 | 0.304 | 0.813 | 214.5k | $402.4k | $259.5k |
| |||||||||||||
| AMLX.NASDAQ | Amylyx Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-06-30 | 1.443 | 0.872 | 981.2k | $3.7m | $2.8m |
| |||||||||||||
| AXSM.NASDAQ | Axsome Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-06-30 | 0.271 | 4.379 | 128k | $274.3k | $12m |
| |||||||||||||
| EOLS.NASDAQ | Evolus Inc | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-06-30 | 0.282 | 1.075 | 177.8k | $54.4k | $2.9m |
| |||||||||||||
| ESPR.NASDAQ | Esperion Therapeutics Inc | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-06-30 | 0.523 | 0.306 | 495.7k | -$869.5k | $867.5k |
| |||||||||||||
| FULC.NASDAQ | Fulcrum Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-06-30 | 0.262 | 0.518 | 163k | $702.1k | $562.5k |
| |||||||||||||
| HROW.NASDAQ | Harrow Health Inc | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-06-30 | 0.38 | 0.661 | 133.3k | $216.2k | $6.1m |
| |||||||||||||
| INVA.NASDAQ | Innoviva Inc | USA | Healthcare | Biotechnology | 2024-06-30 | 0.496 | 2.177 | 345.8k | $3.6m | $6.8m |
| |||||||||||||
| LQDA.NASDAQ | Liquidia Technologies Inc | USA | Healthcare | Biotechnology | 2024-06-30 | 0.25 | 0.974 | 191.6k | $156.6k | $1.9m |
| |||||||||||||
| MNMD.NASDAQ | Mind Medicine Inc | USA | Healthcare | Biotechnology | 2024-06-30 | 0.344 | 0.906 | 279.8k | $694.3k | $1.7m |
| |||||||||||||
| NKTR.NASDAQ | Nektar Therapeutics | USA | Healthcare | Biotechnology | 2024-06-30 | 0.553 | 1.798 | 1m | $393.4k | $1.3m |
| |||||||||||||
| NUVB.NYSE | Nuvation Bio Inc | USA | Healthcare | Biotechnology | 2024-06-30 | 0.042 | 0.238 | 92.6k | $96k | $273.4k |
| |||||||||||||
| OCUL.NASDAQ | Ocular Therapeutix Inc | USA | Healthcare | Biotechnology | 2024-06-30 | 0.371 | 2.726 | 578.2k | $1.3m | $5.2m |
| |||||||||||||
| PANA.NASDAQ | PANA.NASDAQ | - | - | - | - | 0.042 | 0.238 | 92.6k | - | - | ||||||||||||||
| PRVB.NASDAQ | PRVB.NASDAQ | - | - | - | - | 0.28 | 3.393 | 265.7k | - | - | ||||||||||||||
| RETA.NASDAQ | RETA.NASDAQ | - | - | - | - | 0.518 | 3.502 | 189.6k | - | - | ||||||||||||||
| RLMD.NASDAQ | Relmada Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-06-30 | 0.231 | 0.151 | 69.5k | $141.7k | $243.4k |
| |||||||||||||
| ROIV.NASDAQ | Roivant Sciences Ltd | USA | Healthcare | Biotechnology | 2024-06-30 | 0.032 | 0.356 | 221.9k | $1.7m | $2.6m |
| |||||||||||||
| RVNC.NASDAQ | Revance The | USA | Healthcare | Biotechnology | 2024-06-30 | 0.689 | 1.423 | 605.2k | -$753.5k | $3.5m |
| |||||||||||||
| SAVA.NASDAQ | Cassava Sciences Inc | USA | Healthcare | Biotechnology | 2024-06-30 | 0.38 | 2.796 | 182.2k | $717.8k | $5.5m |
| |||||||||||||
| SIGA.NASDAQ | SIGA Technologies Inc | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-06-30 | 0.573 | 1.311 | 413.9k | $966.4k | $3.5m |
| |||||||||||||
| TARS.NASDAQ | Tarsus Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-06-30 | 0.28 | 1.767 | 104.8k | $695k | $3.6m |
| |||||||||||||
| XERS.NASDAQ | Xeris Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-06-30 | 0.212 | 0.475 | 316.2k | -$40.7k | $936.1k |
|
Trades
Adds
Report date: 2023-11-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| AMLX.NASDAQ | 2.9k | 1.0 | 49.6k | 12-22 | $2.88 | -75.6% |
| EOLS.NASDAQ | 1.1k | 1.0 | 10.5k | 7-10 | $16.44 | 121.0% |
| HROW.NASDAQ | 1.3k | 1.0 | 17.8k | 8-17 | $46.47 | 511.4% |
| OCUL.NASDAQ | 3k | 1.0 | 8.7k | 2-4 | $9.04 | 353.1% |
| SAVA.NASDAQ | 2k | 1.0 | 39.5k | 12-25 | $30.36 | 146.4% |
| TARS.NASDAQ | 855.00 | 1.0 | 13.7k | 13-19 | $34.60 | 175.3% |
Report date: 2023-08-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| SAVA.NASDAQ | 1.3k | 0.9 | 28.2k | 17-27 | $30.36 | 83.4% |
Reduces
Report date: 2024-03-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| AMLX.NASDAQ | -20.4k | -2.0 | -267.4k | 3-20 | $2.88 | 7.9% |
| LQDA.NASDAQ | -3.1k | -2.0 | -43.9k | 11-17 | $10.27 | -7.6% |
| SAVA.NASDAQ | -3.8k | -2.0 | -88.2k | 18-27 | $30.36 | 67.0% |
| TARS.NASDAQ | -2.1k | -2.0 | -61.7k | 19-40 | $34.60 | 82.2% |
| XERS.NASDAQ | -8.1k | -2.0 | -21k | 2-3 | $2.96 | 48.0% |
Report date: 2023-06-22
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| AXSM.NASDAQ | -2.4k | -1.8 | -175.1k | 57-91 | $94.32 | 66.2% |
| SAVA.NASDAQ | -2.5k | -1.8 | -61.6k | 21-29 | $30.36 | 41.5% |
Report date: 2023-05-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ACRS.NASDAQ | -3.8k | -1.8 | -32.7k | 6-13 | $1.21 | -79.0% |
| AXSM.NASDAQ | -3k | -1.8 | -205.3k | 54-83 | $94.32 | 75.6% |
| ESPR.NASDAQ | -8.8k | -1.8 | -17.2k | 1-7 | $1.75 | 56.3% |
| SAVA.NASDAQ | -3k | -0.9 | -74.5k | 21-29 | $30.36 | 41.5% |
Report date: 2023-02-28
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| AXSM.NASDAQ | -2.3k | -1.9 | -167.9k | 60-82 | $94.32 | 58.5% |
| ESPR.NASDAQ | -6.5k | -1.9 | -41k | 5-9 | $1.75 | -64.1% |
| PRVB.NASDAQ | -3.8k | -1.9 | -35.1k | 8-11 | - | - |
| SAVA.NASDAQ | -4.5k | -1.9 | -145.6k | 24-45 | $30.36 | 25.9% |
| SIGA.NASDAQ | -7.9k | -1.9 | -59.6k | 6-9 | $8.53 | 31.8% |
Report date: 2022-11-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| AXSM.NASDAQ | -1.1k | -1.0 | -63.5k | 39-80 | $94.32 | 142.7% |
| EOLS.NASDAQ | -2k | -1.0 | -17.1k | 7-11 | $16.44 | 136.0% |
| RETA.NASDAQ | -1.9k | -1.0 | -58.1k | 22-44 | - | - |
| RLMD.NASDAQ | -699.00 | -1.0 | -13.1k | 5-39 | $3.50 | -22.2% |
| SAVA.NASDAQ | -2.2k | -1.0 | -80.2k | 24-52 | $30.36 | 24.4% |
| SIGA.NASDAQ | -5.3k | -1.0 | -55.1k | 8-16 | $8.53 | 3.4% |
Report date: 2022-09-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| AMLX.NASDAQ | -1.9k | -1.0 | -49.2k | 16-33 | $2.88 | -81.8% |
Report date: 2022-03-09
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| NUVB.NYSE | -2k | -2.2 | -13.3k | 4-10 | $2.95 | -33.9% |
| PANA.NASDAQ | -2k | -2.2 | -19.8k | 10-10 | - | - |
Comments
How you think about this?